Journal of the National Cancer Institute Advance Access originally published online on October 14, 2009
JNCI Journal of the National Cancer Institute 2009 101(21):1441-1444; doi:10.1093/jnci/djp398
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© Oxford University Press 2009.
NEWS |
ASCO Rx for High Drug Costs: Doctors and Patients Need To Talk
| The first 150 words of the full text of this article appear below. |
A special task force of the American Society of Clinical Oncology (ASCO) recently issued a Guidance Statement on the Cost of Care, which advises oncologists to speak with their patients about the cost of treatment. While urging ASCO to also address underlying economic factors that drive costs, the guidance focused on issues at the practice level.
"The task force tried to address the rising costs of cancer care and how it affects the practicing of quality medicine and the well-being of the patient," said chair Lowell E. Schnipper, M.D., of Harvard Medical School in Boston.
The statement highlighted a recognized problem: Doctors and patients have difficulty broaching financial topics in the context of an office visit. But it did not offer specific suggestions on how to effect changes necessary for both sides to communicate. In fact, several large, entrenched roadblocks need to be overcome before this kind of communication
Barriers to Discussion
Delegating the Dialogue
The Bigger Picture